Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shyam Nathan"'
Autor:
Shyam Nathan, Yifei Wang, Matthew D’ambrosio, Reeba Paul, Huimin Lyu, Denis Delic, Tom Bretschneider, Kimberly Falana, Li Li, Preethi Vijayaraj
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract Systemic sclerosis (SSc) is an autoimmune disease characterized by vasculopathy, immune dysregulation, and systemic fibrosis. Research on SSc has been hindered largely by lack of relevant models to study the progressive nature of the disease
Externí odkaz:
https://doaj.org/article/4f95fef11cd74158aa182d9c109c859b
Publikováno v:
Respiratory Research, Vol 22, Iss 1, Pp 1-18 (2021)
Abstract Background Lysophosphatidic acid (LPA), generated extracellularly by the action of autotaxin and phospholipase A2, functions through LPA receptors (LPARs) or sphingosine-1-phosphate receptors (S1PRs) to induce pro-fibrotic signaling in the l
Externí odkaz:
https://doaj.org/article/9e2d4f908e8c4f36b832ace6bff5acbd
Autor:
Eliot M. Rosen, Shyam Nathan, Milton L. Brown, Eliseu O. De Oliveira, York A. Tomita, Yongxian Ma
We previously identified small molecules that fit into a BRCA1-binding pocket within estrogen receptor-alpha (ERα), mimic the ability of BRCA1 to inhibit ERα activity (“BRCA1-mimetics”), and overcome antiestrogen resistance. One such compound,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87e5108049e0f3c9d56b15e913222d55
https://europepmc.org/articles/PMC5681404/
https://europepmc.org/articles/PMC5681404/
Autor:
Shyam Nathan, Eliot M. Rosen
Publikováno v:
Cancer Research. 77:3602-3602
Nearly a third of breast cancer patients develop resistance to antiestrogen treatments although the estrogen receptor ER-α continues to affect cell survival and proliferation. Thus there is a need for new interventions to inhibit ER-α function. Bas
Autor:
Eliseu O. De Oliveira, Anju Preet, Eliot M. Rosen, Scott Grindrod, Shyam Nathan, Milton L. Brown, Erikah Englund, Robert Clarke, York Tomita, Yongxian Ma
Context: Resistance to conventional antiestrogens is a major cause of treatment failure and, ultimately, death in breast cancer. Objective: The objective of the study was to identify small-molecule estrogen receptor (ER)-α antagonists that work diff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa8b55bd65a910fd7488b8458938d8eb
https://europepmc.org/articles/PMC4250363/
https://europepmc.org/articles/PMC4250363/